NDC 0641-6044-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6044
- Requested NDC
- 0641-6044-01
- Package NDCs from labels
- 0641-6044-01, 0641-6044-25
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Injection, USP | REMEDYREPACK INC. | 2024-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Lorazepam - TYA Pharmaceuticals | TYA Pharmaceuticals | 2011-11-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6044-01 | Lorazepam | 1 mL in 1 VIAL | INJECTION | 1 | 10 | |
| 0641-6044-25 | Lorazepam | 25 in 1 CARTON | INJECTION | 25 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6044-01 | ML - Milliliter | 0641-6044 | 9c10d57c-be4d-4e5c-bd04-680c477d6ef8 | 1 | 2012-07-24 |
| 0641-6044-25 | ML - Milliliter | 0641-6044 | 6e34d5a1-9495-43ce-a1cb-9f6626a83af7 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE INGREDIENT | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| LORAZEPAM | ACTIVE MOIETY | O26FZP769L | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [TYA PHARMACEUTICALS] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LORAZEPAM INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 99b63d62-1cf0-4f28-8760-773917c2538a | 2025-07-29 | Warnings | 6DC9Q167V3 |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals, Inc. | 00960fbd-a5da-408b-9867-62982f20906f | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals, Inc. | 6cc1f35d-ff33-404e-aa5e-b01eab89863e | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Ativan | LORAZEPAM | Bausch Health US LLC | 89057c93-8155-4040-acec-64e877bd2b4c | 2025-07-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LOREEV XR | LORAZEPAM | A-S Medication Solutions | c470fdee-8e18-4da9-b072-943d6b2518cf | 2025-07-03 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Visine Red Eye Hydrating Comfort Eye Drops | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 | Morning Star OTC | dcd4164c-aa1e-4f07-ab2c-b439275629db | 2025-06-16 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 3c20c89f-c8c3-43b3-837e-da413f449795 | 2025-05-27 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 17919c82-87f2-5030-e063-6294a90ac91a | 2025-04-21 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Golden State Medical Supply, Inc. | 32fb5628-bf80-0135-e063-6294a90aa3ab | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1791d5c9-9004-5c4b-e063-6294a90adf3d | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Bestmade Natural Products BM235 | ACONITE, CACTUS, CRATAEGUS, ALFALFA, CHIONANTHUS, P. GLYCOL | Bestmade Natural Products | 2f82818a-fc34-75e5-e063-6394a90a0301 | 2025-03-04 | Warnings | 6DC9Q167V3 |
| FEELSHION Glycolic Acid Exfoliating Face Pads | PROPYLENE GLYCOL,ARGININE,LACTIC ACID,SALICYLIC ACID,GLYCOLIC ACID | Beijing JUNGE Technology Co., Ltd. | 2e79678c-1ce4-25cf-e063-6394a90a133c | 2025-02-19 | Warnings | 6DC9Q167V3 |
| Code Red Eye Drops Redness Relief | POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL | 4 Trees, LLC | 0aa08018-cc2d-d947-e063-6394a90a914a | 2025-02-07 | Warnings | B697894SGQ |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8aaf9bcb-7a4e-ffaa-e053-2995a90a3913 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | DirectRx | ddcc0b2b-4be2-6d18-e053-2a95a90af987 | 2025-01-22 | Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 4a66b854-4dd6-3746-e054-00144ff8d46c | 2025-01-20 | Warnings, Adverse reactions | O26FZP769L |
| Chemtox | TRITICUM AESTIVUM, BERBERIS VULGARIS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, RHAMNUS PURSHIANA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, LYMPH NODE (SUIS), THYROIDINUM (SUIS), BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, | BioActive Nutritional, Inc. | a480e5f4-5f9e-4b23-b257-b0ac1ebfc115 | 2025-01-07 | Warnings | LKG8494WBH |
| VISTA MEIBO TEARS Propylene Glycol 0.6% w/v Advanced Dry Eye Relief Lubricating Drops 10 ml | PROPYLENE GLYCOL | Red Wedding LLC | b2c2fd0f-b944-6b0b-e053-2995a90aa216 | 2025-01-01 | Warnings | 6DC9Q167V3 |
| Pain Relieving Cream Lidocaine | BENZYL ALCOHOL, LIDOCAINE HCI | Trifecta Pharmaceuticals USA LLC | 039a2036-54b2-cf28-e063-6294a90a8ce6 | 2024-12-31 | Warnings | LKG8494WBH |
| Rite Aid Hydration Lubricant Eye Drops | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | Rite Aid Corporation | ecac1351-e944-21da-e053-2995a90a6d34 | 2024-12-31 | Warnings | 6DC9Q167V3 B697894SGQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.